搜索临床试验以:Β肾上腺素能阻滞剂
总计17806个结果
-
National Cancer Institute (NCI)完全的治疗相关的急性髓性白血病 | 具有 FLT3/ITD 突变的急性髓性白血病 | FLT3基因突变 | 伴有 PML-RARA 的急性早幼粒细胞白血病 | 具有 Inv(16)(p13.1q22) 或 t(16;16)(p13.1;q22) 的急性髓性白血病; CBFB-MYH11 | 急性髓性白血病伴 t(8;21); (q22; q22.1); RUNX1-RUNX1T1美国
-
University of ChicagoForest Laboratories完全的
-
Keimyung University Dongsan Medical CenterChong Kun Dang Pharmaceutical Corp.未知
-
VA Greater Los Angeles Healthcare SystemAstraZeneca完全的
-
GlaxoSmithKline完全的
-
Emory UniversityGeorgia Institute of Technology完全的
-
Memorial Sloan Kettering Cancer Center完全的
-
University of Texas Southwestern Medical CenterNational Heart, Lung, and Blood Institute (NHLBI)完全的
-
University of Sao PauloInstituto do Cancer do Estado de São Paulo; Hospital A.C. Camargo完全的
-
Institute of Liver and Biliary Sciences, India撤销
-
Boston UniversityNational Institute of Mental Health (NIMH)主动,不招人
-
West Virginia UniversityNovoCure Ltd.; West Virginia Clinical and Translational Science Institute撤销
-
Aga Khan UniversityDow University of Health Sciences未知
-
University of Toledo Health Science CampusGlaxoSmithKline终止
-
Cardiovascular Clinical StudiesGlaxoSmithKline完全的
-
OHSU Knight Cancer InstituteOregon Health and Science University; Kuni Foundation招聘中
-
Postgraduate Institute of Medical Education and...招聘中